INNOVATING THE FUTURE
OF WOUND CARE


Imagine a world where one 60-second application changes the game in wound care.
DEBx Medical achieves this with a breakthrough solution for treating hard-to-heal wounds - safer, easier, and faster.
This innovation reduces treatment times (costs) and provides patients with quick discomfort relief, making a significant leap forward in medical practice.

INTRODUCING DEBRICHEM®


A new, disruptive and highly effective method to eliminate biofilm and infection in a matter of seconds in one single application.

TESTIMONIALS

LISTEN TO WHAT DEBRICHEM® USERS SAY
  • The presence of infection and biofilm is a major obstacle to healing, slowing or preventing wound healing, requiring extensive debridement of the affected tissue with additional problems such as aggression of healthy tissue, pain, repeated procedures and added costs of operating theatre, diagnostic tests, local treatment and other procedures.

    The availability of DEBRICHEM® has allowed us to quickly and cost-effectively address the removal of biofilm and infected tissue, facilitating optimal wound bed preparation for early application of other advanced therapies such as grafts or advanced healing products that reduce the time to closure of complex wounds.

    It has also allowed us to rationalise the use of antibiotics and avoid the risk of antibiotic resistance and other problems related to antibiotic treatments.
    Dr. Joan Enric Torra i Bou
    Clinical Consultant and researcher. Doctorate Programme in Health Sciences, Universitat de Lleida, Lleida, Spain.
    Tissue Repair and Regeneration Laboratory (TR2Lab), Institut de Recerca i Innovació en Ciències de la Vida i de la Salut a la Catalunya Central (IrisCC), Vic.
    Barcelona, Spain
  • "I've been trying DEBRICHEM® on patients with diabetic foot emergencies (foot attack) with necrotizing fasciitis and who are also septic.

    What I have observed so far is the rapid control of the local infection and the early appearance of healthy granulation tissue."
    H.Erhan Güven,M.D.
    Assoc.Prof.of Surgery
    Chief Physician, General Hospital, Ankara Etlik City Hospital
    Director, Chronic Wounds and Diabetic Foot Department, Ankara Etlik City Hospital
  • "Some infected wounds are difficult to debride without taking the patient to the OR.
    Where there is exuberant lumpy bumpy irregular granulation tissue for example.

    In my experience one application of DEBRICHEM® will completely solve that problem.
    By the next week you will be left with a perfectly healthy wound bed."
    Professor Steven Jeffery
    Medical Director Pioneer Sussex Wound Healing and Lymphoedema Centres
  • "Biofilm is an enemy to wound healing. Imagine working on a Monday morning in a clinic setting where workload is way out of hand, and you have a patient that needs for a debridement but you are not free to do so, patient has high risk of bleeding and cannot tolera- te pain that well, but you still need to remove the biofilm and bioburden.

    What's the quickest and fastest way without compromising the good tissues? DEBRICHEM® by DEBX Medical is the answer. With a few drops from 'heaven; your biofilm eradication works like magic. Even fairy godmother won't be able to do this trick that fast. Surely the result will stun you.

    Furthermore, it reduces your time to attend to patient, reduces the cost of patient's visit, no hospitalization, no bleeding and definitely, a fast desirable outcome."
    Dr. HELMI RASHIDI
    Head of of Wound Care Unit Hospital Ampang Malaysia

STAY INFORMED, STAY INSPIRED

JOIN OUR CIRCLE OF INNOVATION!

DEBRICHEM®

APPLICATION PROCESS

REMOVES BIOFILM & INFECTION


DEBRICHEM® offers and straightforward and fast application process suitable for ambulatory settings, making it accessible for healthcare professionals: doctors and nurses. Unlike traditional debriding methods, it doesn’t require a specific training.

EXCITING HIGHLIGHTS FROM EWMA 2024!



Event
DEBx Medical is proud to share the highlights from our presence at the EWMA (European Wound Management Association) Conference in London! The event was a resounding success, filled with engaging symposiums, insightful booth talks, and dynamic interactions with clinicians, distributors, and partners from around the globe. Attendees experienced firsthand how DEBRICHEM® is revolutionizing wound care.
Watch our after-movie and immerse yourself in the energy of this incredible event.

Company Dinner
We had the pleasure of hosting an exclusive dinner with over 70 guests from 18 nationalities. This diverse gathering showcased the global reach and impact of DEBRICHEM®. The evening was a fantastic opportunity to connect, share experiences, and celebrate our collective achievements in wound care.

IMPROVING LIVES

BY EFFICIENCY IN WOUND TREATMENT


For patients, a swifter recovery and less discomfort lead to a speedy return to daily life with minimal stress.

Healthcare professionals experience simplified workflows, allowing for effective patient management and quicker, satisfying treatment outcomes.

Hospitals and clinics benefit from reduced operational costs and increased efficiency, positively impacting patient throughput and satisfaction.

DEBRICHEM® accelerates healing and improves the treatment experience by making it a win-win for patients and healthcare providers.

VIDEO
PRESENTATION

COMBATTING

THE SILENT EPIDEMIC


Hard-to-heal wounds represent a global health silent epidemic.
It is estimated that 1,2 out of 10 people in developed countries will suffer from a chronic wound in their lifetime.
This number is projected to increase by 2% over the next decade.
For these people every day is a struggle. They often live with severe chronic pain, limited mobility, and a great sense of isolation.

ELIMINATING INFECTION

IN SECONDS


The presence of an infection in hard-to-heal wounds prolongs the recovery time and significantly increases the risk of complications, including amputation in most severe cases.
We have developed a valid fast and safe alternative to surgical debridement.
Our innovative product eliminates the infection (biofilm) in hard-to-heal wounds in one single 60-second application.

UPCOMING EVENT

WITH DEBx MEDICAL


2-5 OCTOBER 2024
OCTOBER 2-5

Pisa, Italy

Diabetic Foot Course 2024 - PISA

KEEP ME INFORMED



    By clicking on "submit query", I confirm that I have read, understood and agree to the privacy policy of this website.

    DEBx MEDICAL

    A GLOBAL FORCE IN WOUND CARE




    From the Netherlands, DEBx Medical's headquarters is the beating heart of a vast and unified global network. Together, with dedicated partners worldwide, we form a dynamic alliance. Our collaborative spirit and effective operational strategies ensure that our advancements in wound care are experienced globally.
    With an eye on the future, we're laying the groundwork for significant milestones, including filing for FDA approval in 2024. Our mission is clear: to revolutionize wound care globally, one patient at a time.

    CONTACT DEBx MEDICAL

    Want to know more about our product portfolio or have any questions?
    Get in touch with us!





      By clicking on "submit query", I confirm that I have read, understood and agree to the privacy policy of this website.

      By clicking on "submit query", I confirm that I have read, understood and agree. to the privacy policy of this website.




      OUR TEAM CAN'T WAIT TO CONNECT WITH YOU
      AND PROVIDE THE INFORMATION YOU NEED